From Screening to Solutions in Gestational Diabetes Diagnostics

Webinars & Videos

Published 11/20/25

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Diagnostic tests and procedures offer opportunities to detect diseases earlier, guide intervention choices, and monitor and evaluate treatment effectiveness. Some diagnostic tests are invasive, such as a biopsy or endoscopy, whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Screening and diagnostic testing can help improve health outcomes and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively, differently, or disproportionately affect women is invaluable in furthering women’s health across sectors.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discuss how to improve health outcomes for diseases and conditions that disproportionately or differently affect women, with special a focus on maternal health.

The 2025 SWHR Value of Diagnostics within Women’s Health series includes:

View the original event page here: From Screening to Solutions in Gestational Diabetes Diagnostics.

Goals

  • Discuss the impacts of preeclampsia on women’s health, including disparities in disease burden, access to care, and long-term health outcomes
  • Highlight current innovations in preeclampsia diagnostics and how they can support proactive, personalized care
  • Share insights on integrating screening and monitoring into clinical practice to reduce complications and improve long-term health for mothers

Panelist

Maisa Feghali, MD, MS

Associate Professor, Department of Obstetrics and Gynecology, University of Pittsburgh, Magee Women's Research Institute

Maisa Feghali, MD, MS

Associate Professor, Department of Obstetrics and Gynecology, University of Pittsburgh, Magee Women's Research Institute

Dr. Feghali is an Associate Professor in the Department of Obstetrics and Gynecology and the division of Maternal Fetal Medicine. She leads the diabetes in pregnancy program at Magee Womens Hospital of UPMC. Her research has examined predictors of treatment response and neonatal adverse outcomes in women with diabetes in pregnancy. Her current work focuses on the variation in pathophysiology of diabetes in pregnancy and the potential role of individualized therapy.

The event is moderated by Syreen Goulmamine, MPH, CHES®, Science Programs Manager at the Society for Women’s Health Research.

Sponsor

Support for this educational program has been provided by Roche Diagnostics. SWHR maintains independence and editorial control over program development, content, and work products.